Susquehanna International Group
BLCM

Susquehanna International Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Susquehanna International Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,300
Closed -$99K – 11195
2020
Q1 		$99K Buy
21,300
+20,040
+1,590% +$215K ﹤0.01% 9332
2019
Q4 		$16K Buy
1,260
+160
+15% +$1.48K ﹤0.01% 9514
2019
Q3 		$12K Sell
1,100
-900
-45% -$11.8K ﹤0.01% 10004
2019
Q2 		$34K Sell
2,000
-30
-1% -$812 ﹤0.01% 9921
2019
Q1 		$68K Buy
+2,030
New +$67.9K ﹤0.01% 8395
2018
Q4 		– Sell
-2,080
Closed -$128K – 10252
2018
Q3 		$128K Sell
2,080
-10,700
-84% -$724K ﹤0.01% 8500
2018
Q2 		$943K Sell
12,780
-2,300
-15% -$179K ﹤0.01% 5487
2018
Q1 		$989K Buy
15,080
+1,050
+7% +$79.3K ﹤0.01% 5262
2017
Q4 		$1.18M Buy
14,030
+3,940
+39% +$386K ﹤0.01% 4908
2017
Q3 		$1.17M Sell
10,090
-6,790
-40% -$714K ﹤0.01% 5002
2017
Q2 		$1.97M Buy
16,880
+5,770
+52% +$716K ﹤0.01% 3933
2017
Q1 		$1.37M Buy
11,110
+6,900
+164% +$904K ﹤0.01% 4463
2016
Q4 		$573K Sell
4,210
-1,490
-26% -$265K ﹤0.01% 6699
2016
Q3 		$1.13M Buy
5,700
+1,830
+47% +$315K ﹤0.01% 4569
2016
Q2 		$502K Sell
3,870
-3,450
-47% -$384K ﹤0.01% 6124
2016
Q1 		$684K Sell
7,320
-1,250
-15% -$136K ﹤0.01% 5839
2015
Q4 		$1.74M Sell
8,570
-4,740
-36% -$848K ﹤0.01% 4336
2015
Q3 		$1.93M Buy
13,310
+3,600
+37% +$661K ﹤0.01% 4350
2015
Q2 		$2.06M Buy
9,710
+8,020
+475% +$1.97M ﹤0.01% 4652
2015
Q1 		$392K Buy
+1,690
New +$409K ﹤0.01% 7540

Other funds holding BLCM

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Susquehanna International Group's BLCM Position: Q2 2023 in Review

Susquehanna International Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 30,177 shares — an estimated $9.96K sold.

Susquehanna International Group first reported a position in BLCM in Q1 2015 and held it in 23 quarters. The position peaked at $4.28M in Q3 2017. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

  • Susquehanna International Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 30,177 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $9.96K.
  • Susquehanna International Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 23 quarters.
  • Susquehanna International Group's Bellicum Pharmaceuticals, Inc. position peaked at $4.28M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.